Every Form 4 that Alignment Healthcare, Inc. (ALHC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ALHC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALHC filings page.
Alignment Healthcare, Inc. (ALHC) reported that EVP, Corporate Affairs Joseph S. Konowiecki, a director and officer, sold 23,511 shares of common stock on September 17, 2026 at a weighted-average price of $8.61 per share. According to the disclosure, the sale was made to cover tax withholding obligations arising from the vesting of restricted stock units and is described as not a discretionary trade. Following this transaction, Konowiecki directly holds 1,080,305 shares of Alignment Healthcare common stock.
Alignment Healthcare, Inc. (ALHC) reported that Chief Executive Officer and director John E. Kao sold 27,400 shares of common stock on September 14, 2026 at $13.00 per share, in a sale described as a Rule 10b5-1 plan transaction and executed through an indirect holding.
The sold shares were held by the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee; following this transaction, that trust held 590,766 shares indirectly. Separately, Mr. Kao also reported a direct holding of 1,223,473 shares of Alignment Healthcare common stock as of the same date.
Alignment Healthcare, Inc. (ALHC) reported that President Dawn Christine Maroney sold 122,707 shares of common stock on September 11, 2026. The shares were sold at a weighted-average price of $12.68 per share in multiple trades between $12.394 and $13.17 to cover tax withholding obligations arising from the vesting of restricted stock units, and the company notes this was not a discretionary trade. Following these sales, Maroney directly holds 794,606 shares of Alignment Healthcare common stock.
Alignment Healthcare, Inc. (ALHC) reported that Chief Executive Officer and director John E. Kao disclosed two sales of common stock totaling 557,870 shares.
On September 11, 2026, Kao sold 385,270 shares at a weighted-average price of $12.68 per share, in multiple trades between $12.394 and $13.17, to cover tax withholding obligations arising from the vesting of restricted stock units; the filing states this was not a discretionary trade. After this sale, he held 1,223,473 shares directly.
On September 10, 2026, a trust associated with Kao, the JEK Trust dated February 8, 2021, sold 172,600 shares at a weighted-average price of $12.96 per share, in trades between $12.71 and $13.21, under a Rule 10b5-1 trading plan adopted on May 27, 2026. These shares are reported as held indirectly, with 618,166 shares remaining in the trust after the transaction.
Alignment Healthcare, Inc. (ALHC) reported an insider transaction by President Dawn Christine Maroney. On 2026-08-14, she sold 5,000 shares of common stock at $14.00 per share in an open-market or private transaction. After this sale, she directly held 917,313 shares of Alignment Healthcare common stock. The transaction was carried out under a Rule 10b5-1 trading plan adopted on 2026-03-13.
Alignment Healthcare, Inc. insider John E. Kao, Chief Executive Officer and director, reported selling 298,000 shares of common stock on 2026-08-10 at a weighted-average price of $13.8818 per share, in multiple trades between $13.62 and $14.30. The sold shares are held indirectly through the JEK Trust, where Mr. Kao serves as trustee, leaving 790,766 common shares held indirectly after the sale. A separate entry shows 1,608,743 common shares held directly as of the same date. The filing states that the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on 11/21/2025.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an option exercise and related stock sale. She exercised options to acquire 152,068 shares of common stock at $9.0600 per share and sold 177,068 shares in open-market transactions at a weighted-average price of $20.8281 per share under a Rule 10b5-1 trading plan adopted on 3/13/26, with individual sale prices ranging from $20.29 to $21.14. The exercised options, granted on 03/08/2022, vested 25% on each of the first four anniversaries of the grant date.
Alignment Healthcare, Inc. CEO and director John E. Kao reported open-market sales of 298,000 shares of common stock on July 10, 2026. The shares were sold in multiple transactions at weighted-average prices of $19.8122 and $20.6471 per share under a Rule 10b5-1 trading plan adopted on November 21, 2025, and include sales from a trust for which Mr. Kao serves as trustee.
Hochradel Shane J. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Operations Officer Shane J. Hochradel received an award of 87,719 restricted stock units, each representing the right to receive one share of common stock. These RSUs vest in roughly equal installments on March 13, 2027, 2028 and 2029, conditioned on his continued service. Following this compensation-related grant, his reported holdings from this award total 87,719 units.
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, sold 25,000 shares of common stock in an open-market transaction at $24.00 per share. The sale was made under a Rule 10b5-1 trading plan adopted on 03/04/2026. After this transaction, he directly holds 1,103,816 shares, so the sale represents a relatively small portion of his overall stake.
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, reported an open-market sale of 25,000 shares of Common Stock at $23.00 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 03/04/2026, indicating it was pre-arranged. After the sale, he directly owns 1,128,816 shares, so the transaction represents a relatively small portion of his overall holdings.
Alignment Healthcare executive reports planned stock sale. EVP of Corporate Affairs Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare, Inc. common stock in an open-market transaction at $22.00 per share. Following this sale, he directly holds 1,153,816 shares. A footnote states the transaction was carried out under a Rule 10b5-1 trading plan adopted on 03/04/2026, indicating the sale was pre-arranged rather than timed discretionarily.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock at a weighted-average price of $19.5475 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on May 22, 2025. After this sale, she directly holds 947,313 shares, indicating a large remaining ownership position.
Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of common stock. On June 12, 2026, Kim sold 35,951 shares at a weighted-average price of $19.8589 per share under a pre-arranged Rule 10b5-1 plan adopted on March 13, 2026.
After this transaction, Kim directly holds 331,750 shares of Alignment Healthcare common stock. The filing shows a single net-sell transaction with no derivative exercises or gifts disclosed in this report.
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, reported an open-market sale of company stock. On June 11, 2026, he sold 25,000 shares of Common Stock at $21.00 per share in a non-derivative transaction.
After this sale, he directly holds 1,178,816 shares of Alignment Healthcare common stock. The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2026, indicating it was scheduled in advance rather than timed opportunistically.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported indirect open-market sales of company common stock made through the JEK Trust, of which he is trustee. On June 10, 2026, the trust sold 223,064 shares at a weighted-average price of $20.5962 per share and 74,936 shares at a weighted-average price of $19.6481 per share, under a Rule 10b5-1 trading plan adopted on November 21, 2025. Following these transactions, the JEK Trust held 1,609,830 shares indirectly, while Mr. Kao’s direct holdings were 1,608,743 shares, after a transfer of 176,125 shares from direct ownership to the trust.
Kent Mark D. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that President - MSO Mark D. Kent received a grant of 87,719 restricted stock units of Common Stock. These units vest in roughly equal one-third installments on March 13, 2027, 2028 and 2029, contingent on continued service, bringing his direct holdings to 102,567 shares.
KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare EVP Corporate Affairs Joseph S. Konowiecki received a grant of 122,807 restricted stock units of common stock. The award was made at no cash cost to him and is compensation-related rather than an open‑market purchase.
Each restricted stock unit represents one share of Alignment Healthcare common stock. The units will vest in three roughly equal installments on March 13, 2027, March 13, 2028 and March 13, 2029, as long as he continues serving the company on those dates. After this grant, he directly holds 1,203,816 shares of common stock.
Alignment Healthcare, Inc. President - MSO Mark D. Kent reported an open-market purchase of 14,848 shares of Common Stock at $13.31 per share on June 2, 2026. Following this transaction, he directly holds 14,848 shares.
Alignment Healthcare, Inc. President Dawn Christine Maroney reported insider transactions in common stock. She sold 30,000 shares in an open-market sale at a weighted-average price of $16.0855 per share under a Rule 10b5-1 plan adopted on 05/22/25. She also made bona fide gifts totaling 21,500 shares to a family member and a charitable donor advised fund. After these transactions, she directly holds 977,313 shares.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported open-market sales of a total of 298,000 shares of common stock on May 11, 2026 through an entity associated with him. The transactions were executed at weighted-average prices of $16.8494 and $17.5350 per share, across ranges from $16.22 to $17.70. According to a footnote, the sold shares are held by the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee. Following these sales, an indirect holding entry shows 1,508,641 shares and a separate direct holding entry shows 1,784,868 shares owned after the reported transactions. A footnote also provides the date of a Rule 10b5-1 plan adoption as November 21, 2025.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported an open-market sale of 30,000 shares of common stock. The shares were sold at a weighted-average price of $20.8733 per share under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, Maroney directly holds 1,028,813 shares of Alignment Healthcare common stock. The sale was executed in multiple trades at prices ranging from $20.76 to $21.07 per share.
Alignment Healthcare, Inc. director and CEO John E. Kao reported open-market sales of a total of 298,000 shares of Common Stock held indirectly through the JEK Trust, where he serves as trustee. The sales, executed under a Rule 10b5-1 plan adopted on 11/21/2025, were completed at weighted-average prices ranging from $20.26 to $21.49 per share across multiple trades. Following these transactions, the JEK Trust held 1,806,641 shares indirectly, and Kao also reported 1,784,868 shares held directly as of 04/10/2026.
Alignment Healthcare, Inc. Chief Financial Officer James M. Head reported a mandatory share sale tied to equity compensation. On April 7, 2026, he disposed of 11,100 shares of common stock at $21.08 per share to cover tax withholding obligations from vesting restricted stock units. A footnote explains this was not a discretionary trade. After this transaction, he directly holds 173,495 shares of Alignment Healthcare common stock.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported open-market sales of a total of 250,000 shares of Common Stock on April 7, 2026, through indirect holdings. The sales occurred at weighted-average prices of $20.67 and $21.3953 per share.
The indirectly held shares are owned by the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee. After these transactions, he continues to hold 2,104,641 shares indirectly and 1,784,868 shares directly. The sales were made pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2025.
Alignment Healthcare, Inc. reported that Chief Legal and Admin. Officer Christopher J. Joyce sold 18,013 shares of common stock in an open-market transaction. The weighted-average sale price was $17.7923 per share, within a range of $17.57 to $17.99. Following this sale, he directly holds 305,451 shares. The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on 09/08/2025.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported an open-market sale of 118,000 shares of Common Stock at a weighted-average price of $17.4783 per share. The sale was effected indirectly through JEK Trust, dated February 8, 2021, for which he serves as trustee, under a Rule 10b5-1 trading plan adopted on November 21, 2025. Following the transaction, indirect holdings through the trust were 2,354,641 shares, and a separate holding entry shows 1,784,868 shares held directly.
Alignment Healthcare COO Sebastian Burzacchi reported an open-market sale of 15,361 shares of common stock. The shares were sold at a weighted-average price of $17.84 per share, in multiple trades between $17.40 and $18.24. According to the disclosure, the sale was required to cover tax withholding obligations tied to the vesting of restricted stock units and is described as non-discretionary. After this transaction, Burzacchi directly holds 258,630 shares.
Alignment Healthcare, Inc. Chief Medical Officer Hyong Kim reported an open-market sale of 18,404 shares of common stock at a weighted-average price of $17.84 per share. According to the filing, these shares were sold solely to cover tax withholding obligations from vesting restricted stock units and did not represent a discretionary trade.
After this transaction, Kim directly holds 367,701 shares of Alignment Healthcare common stock. The shares were sold in multiple trades at prices ranging from $17.40 to $18.24 per share.
Alignment Healthcare, Inc. Chief Legal and Administrative Officer Christopher J. Joyce reported an open-market sale of 25,125 shares of common stock on March 18, 2026. The shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not a discretionary trade.
The weighted-average sale price was $17.84 per share, with individual trades ranging from $17.40 to $18.24. After this tax-related sale, Joyce directly holds 323,464 shares of Alignment Healthcare common stock.
Alignment Healthcare, Inc. President Dawn Christine Maroney reported a mandatory sale of 36,749 shares of common stock. The shares were sold in open-market transactions at a weighted-average price of $17.84 per share to cover tax withholding obligations from vesting restricted stock units, and are described as non-discretionary. Following these transactions, Maroney directly holds 1,058,813 shares of Alignment Healthcare common stock. Individual sales occurred at prices ranging from $17.40 to $18.24 per share.
Alignment Healthcare, Inc. Chief Executive Officer John E. Kao reported an open-market sale of 73,046 shares of common stock at a weighted-average price of $17.84 per share. According to the disclosure, these shares were sold to cover tax withholding obligations arising from vesting of restricted stock units and did not represent a discretionary trade.
After the sale, Kao directly owned 1,784,868 common shares. He also had an additional 2,472,641 shares held indirectly through the JEK Trust dated February 8, 2021, for which he serves as trustee.
Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported an open-market sale of 11,285 shares of common stock. The shares were sold primarily to cover tax withholding obligations tied to the vesting of restricted stock units, so the transaction was not a discretionary trade. The weighted-average sale price was $17.84 per share, with individual trades ranging from $17.40 to $18.24. After this tax-related sale, Scavo holds 487,685 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. Chief Human Resources Officer Andreas P. Wagner reported open-market sales of Alignment Healthcare common stock primarily to cover tax withholding from vesting restricted stock units. He sold 12,000 shares on March 18, 2026 at a weighted-average price of $17.84 per share and 11,602 shares on March 19, 2026 at a weighted-average price of $18.2207 per share.
The filing states these sales were required to satisfy tax obligations and "do not represent a discretionary trade" by Wagner, and were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025. After these transactions, he directly holds 148,628 shares of Alignment Healthcare common stock.
Wagner Andreas P. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner received an equity grant in the form of restricted stock units. The award covers 23,543 units, each representing one share of common stock. These units vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service with the company. Following this grant, Wagner directly holds 172,230 shares of Alignment Healthcare common stock, reflecting both existing ownership and the new award.
Burzacchi Sebastian reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that COO - Mgmt Services Org Sebastian Burzacchi received a grant of 36,198 shares of Common Stock in the form of restricted stock units. These units carry no purchase price and increase his direct holdings to 273,991 shares after the award.
According to the terms, the 36,198 restricted stock units will vest in three approximately equal installments on each of the first three anniversaries of the grant date, as long as Burzacchi continues to provide service to the company on each vesting date. This is a compensation-related equity award rather than an open‑market share purchase.
Mansour Adnan R. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare reported that Chief Digital Officer Adnan R. Mansour received a grant of 25,015 restricted stock units of Common Stock on March 13, 2026. These RSUs vest in roughly one-third increments on each of the first three anniversaries of the grant date, if he continues serving the company. After this award, he directly holds 48,456 shares or units tied to Alignment Healthcare stock. This transaction reflects equity-based compensation rather than an open-market purchase.
JOYCE CHRISTOPHER J reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Legal and Administrative Officer Christopher J. Joyce received an equity grant of 51,501 shares of Common Stock in the form of restricted stock units. These units were awarded at no cash cost per share as part of his compensation.
The 51,501 restricted stock units will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, as long as he continues serving the company through each vesting date. After this grant, he directly holds 348,589 shares of the company’s Common Stock.
Kim Hyong reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Medical Officer Hyong Kim received an equity grant of 52,972 shares of Common Stock in the form of restricted stock units at no cash cost. These units vest in roughly equal thirds on each of the first three anniversaries of the grant date, contingent on continued service. Following this grant, Kim holds 386,105 shares directly, underscoring this as a routine, compensation-related award rather than an open-market purchase.
Head James M reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that its Chief Financial Officer, James M. Head, received a grant of 103,002 restricted stock units of common stock. Each unit represents one share and will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service. Following this award, his direct common stock holdings total 184,595 shares.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported mixed insider activity in Common Stock. On March 13, 2026, she received 161,860 restricted stock units, each representing one share, which will vest in roughly equal thirds on each of the first three anniversaries of the grant date, subject to continued service.
On March 16, 2026, she completed an open-market sale of 30,000 shares at a weighted-average price of $17.4809 per share, with individual sale prices ranging from $17.12 to $17.60. Following the sale, she directly held 1,095,562 shares of Common Stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on May 22, 2025.
KAO JOHN E reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that Chief Executive Officer John E. Kao received a grant of 338,434 restricted stock units of Common Stock on March 13, 2026. The grant was made at no cash purchase price as a stock-based compensation award.
Each restricted stock unit represents the right to receive one share of Common Stock and will vest approximately one third on each of the first three anniversaries of the grant date, subject to Mr. Kao’s continued service with the company. Following this grant, he holds 1,857,914 shares directly and 2,472,641 shares indirectly through the JEK Trust, of which he is trustee.
Vorhoff Nicholas Robbert reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. disclosed that director Nicholas Robbert Vorhoff was granted 18,982 restricted stock units, each representing one share of common stock. These units vest on the one-year anniversary of the grant date if he continues serving on the Board.
The filing shows 173,408 common shares credited to his direct holdings after the grant. According to the footnote, the RSUs are held solely for the benefit of General Atlantic Service Company, L.P., and Vorhoff disclaims beneficial ownership of both the RSUs and the underlying common stock.
McClellan Mark B. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Mark B. McClellan received an equity award of 13,096 restricted stock units of Common Stock. These units were granted at no cash cost and will vest on the one-year anniversary of the grant date, provided he continues serving on the Board of Directors. After this grant, he holds 370,531 shares directly, reflecting routine, compensation-related equity alignment with shareholders rather than an open-market purchase.
McCarthy Margaret M reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Margaret M. McCarthy reported receiving a grant of 14,273 restricted stock units (RSUs), each representing one share of common stock. All RSUs will vest on the one-year anniversary of the grant date if she continues serving on the Board of Directors. Following this award, she directly holds 144,441 shares. She has elected to defer receipt of the underlying shares until she separates from service as a director or a change of control of the company occurs.
KOSECOFF JACQUELINE B reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Jacqueline B. Kosecoff reported an equity grant of 13,096 shares of Common Stock in the form of restricted stock units. These RSUs were awarded at no cash cost to her as a standard grant, not an open-market purchase.
Each restricted stock unit represents one share of Common Stock and will fully vest on the one-year anniversary of the grant date, assuming she continues to serve on the Board of Directors through that date. Following this grant, she directly holds 303,963 shares, including the new award.
KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Joseph S. Konowiecki received a grant of 24,868 restricted stock units, each representing one share of common stock. These RSUs will fully vest on the first anniversary of the grant date, provided he continues serving on the Board. He has elected to defer receipt of the underlying shares for three years, or earlier upon separation of service or a change of control. Following this award, he holds 1,081,009 shares directly.
JORDEN YON reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare director Jorden Yon received a new equity grant. The filing shows an award of 13,096 restricted stock units of Alignment Healthcare, Inc. common stock, with no cash paid per share. After this grant, Yon directly holds 105,830 shares or share equivalents.
Each of the 13,096 restricted stock units represents a right to receive one share of common stock. The entire grant will vest on the one-year anniversary of the grant date, as long as Yon continues serving on the Board of Directors through that date.
HODGSON DAVID C reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare reported an equity award linked to director David C. Hodgson. The filing shows a grant of 18,982 restricted stock units, each representing one share of common stock, bringing the reported post‑grant balance to 173,408 shares.
The restricted stock units are scheduled to vest on the one-year anniversary of the grant date as long as Hodgson continues serving on the Board of Directors through that date. He has elected to defer receipt of the underlying shares until separation of service as a director, or earlier if there is a change of control of the company.
The award is held solely for the benefit of General Atlantic Service Company, L.P., and Hodgson disclaims beneficial ownership of both the restricted stock units and the underlying common stock. This indicates the economic interest is attributed to the affiliated entity rather than to him personally.
BILNEY JODY L reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. director Jody L. Bilney received a grant of 16,039 restricted stock units on March 13, 2026. Each unit represents one share of common stock and will vest on the one-year anniversary of the grant date if she continues serving on the board. Bilney has elected to defer delivery of the shares until separation from service or an earlier change of control of the company. Following this award, she holds 129,267 shares of common stock directly.